TABLE 3.
Relative odds of having an elevated SUA levels among 5,404 12–19 year-old adolescents, NHANES 1999–2006.
Elevated SUA OR (95%CI), P-value |
||||
Lg Hcy, μ mol/L | Events (%) | Model 1 | Model 2 | Model 3 |
Per 1, μmol/L increase | 1813 (33.55%) | 13.80 (7.35, 25.91), <0.001 | 14.57 (7.68, 27.64), <0.001 | 8.80 (4.25, 18.20), <0.001 |
Tertiles | ||||
T1 (<5.07) | 362 (20.19%) | 1 | 1 | 1 |
T2 (5.07–6.34) | 556 (30.91%) | 1.29 (1.07, 1.54), 0.007 | 1.30 (1.09, 1.57), 0.005 | 1.18 (0.97, 1.43), 0.090 |
T3 (≥6.34) | 895 (49.39%) | 2.20 (1.82, 2.65), <0.001 | 2.25 (1.86, 2.73), <0.001 | 1.92 (1.55, 2.37), <0.001 |
P for trend | <0.001 | <0.001 | <0.001 |
Model 1 was adjusted for age, sex, BMI, SBP, DBP. Model 2 was adjusted for age, sex, BMI, SBP, DBP, non-Hispanic White, non-Hispanic Black, Mexican American, Other Hispanic, Other races, education. Model 3 was adjusted for age, sex, BMI, SBP, DBP, non-Hispanic White, non-Hispanic Black, Mexican American, Other Hispanic, Other races, education, FBG, Triglycerides, TC, eGFR, BUN, CRP, Serum folate, Serum Vitamin B12, ALT, AST, GGT, Vitamin B12 intake, Vitamin B6 intake.